Astrid C P Swinkels

Netherlands Comprehensive Cancer Organisation — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index674citations22works13.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(8), Breast Cancer Treatment Studies(7), Advanced Breast Cancer Therapies(5), Cancer Risks and Factors(4), Bone health and osteoporosis research(3)

Publications22 total

Author Correction: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer
Nature·2025Open Access
The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial
ESMO Open·2025· 13 citedOpen Access
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer
Nature·2024· 50 citedOpen Access
Development and Implementation of Standardized, Structured Clinical Reporting for Oncology
Studies in health technology and informatics·2024· 1 citedOpen Access
Development and Implementation of Semantic Information Standards for Oncology
Studies in health technology and informatics·2024· 2 citedOpen Access
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer
JNCI Cancer Spectrum·2023· 6 citedOpen Access
Primary outcome analysis of the phase 3 SONIA trial (BOOG 2017-03) on selecting the optimal position of cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors for patients with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC).
Journal of Clinical Oncology·2023· 89 cited
94MO The prognostic and predictive effect of BMI in postmenopausal HR+ breast cancer patients receiving (extended) endocrine therapy: DATA trial analysis
ESMO Open·2023Open Access
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial
EClinicalMedicine·2023· 14 citedOpen Access
133O Extended adjuvant aromatase inhibition after sequential endocrine therapy: Final results of the phase III DATA trial
Annals of Oncology·2022· 5 cited
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial
Breast Cancer Research and Treatment·2020· 8 citedOpen Access
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study
International Journal of Cancer·2019· 13 citedOpen Access
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy‐induced ovarian function failure
International Journal of Cancer·2018· 12 citedOpen Access
Assessment and management of bone health in women treated with adjuvant anastrozole in the DATA study.
Journal of Clinical Oncology·2018
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial
The Lancet Oncology·2017· 157 cited
Anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.
Journal of Clinical Oncology·2017· 2 cited
Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure
JNCI Journal of the National Cancer Institute·2017· 31 citedOpen Access
Purification, Quantification, and Functional Analysis of Complement Factor H
Methods in molecular biology·2013· 8 cited
Self-management of fatigue in rheumatoid arthritis: a randomised controlled trial of group cognitive-behavioural therapy
Annals of the Rheumatic Diseases·2011· 195 citedOpen Access
Concurrent Oral 5 - BHPR Audit/Service Delivery and Research [OP32-OP39]: OP32. Is Nurse-Led Care Effective in Rheumatology? a Systematic Review
Lara D. Veeken·2010· 1 cited
page 1 of 2Next →

Frequent Co-authors

Carolien H. Smorenburg(12), Judith R. Kroep(12), Aafke H. Honkoop(12), Frans Erdkamp(11), Vivianne C. G. Tjan‐Heijnen(10), W Roos(10), Sabine C. Linn(10), Alexander L.T. Imholz(10), Hiltje de Graaf(9), Maurice J.C. van der Sangen(8), Ingeborg J. H. Vriens(8), Irene E.G. van Hellemond(7), Petronella G.M. Peer(7), Maaike de Boer(7), Caroline Seynaeve(7), Franchette W.P.J. van den Berkmortel(6), Sandra M. E. Geurts(5), Aart Beeker(4), Paul C. de Jong(4), Quirine C. van Rossum‐Schornagel(4)